Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Rhabdomyolysis in Severe Covid19: A Mini Review Study Publisher



Taebi M1 ; Tajik A2 ; Zarepur A3 ; Zarepur E4 ; Tavakolimoghadam R5 ; Danesh H6
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Anesthesia, Faculty of Allied Medicine, Kerman University of Medical sciences, Kerman, Iran
  2. 2. Department of Biology, Faculty of Sciences, University of Guilan, Iran
  3. 3. Hormozgan University of Medical Sciences, Hormozgan, Iran
  4. 4. Isfahan University of Medical Sciences, Isfahan, Iran
  5. 5. Department of Pathology, Atieh hospital, Tehran, Iran
  6. 6. Zahedan university of Medical Sciences (ZUMS), Iran

Source: Journal of Medicinal and Chemical Sciences Published:2022


Abstract

Introduction: Rhabdomyolysis can be a symptom of COVID-19, with very few cases described so far. AKI and renal failure following rhabdomyolysis are a potentially dangerous complication. Diagnosis of rhabdomyolysis in COVID-19 is difficult due to overlap. Materials and Method: The present study was a PICO review that examined rhabdomyolysis in COVID-19. The documents browsed by Google Scholar, Sid and Mag Iran databases were analyzed using the keywords rhabdomyolysis, creatine kinase, COVID-19, acute renal failure. Results: Rhabdomyolysis following COVID-19 and SARS-CoV-2 reports of viral contamination of striated muscle may result in muscle destruction. Rhabdomyolysis in COVID-19 is a late complication. Evaluation of CK and myoglobin levels is important for the diagnosis of rhabdomyolysis in COVID19 patients. The mechanism of rhabdomyolysis in COVID-19 is unknown and various mechanisms are used. Conclusion: Rhabdomyolysis may cause acute kidney damage (AKI). Prompt diagnosis is a prerequisite for successful treatment and prevention of complications. © 2022 by SPC (Sami Publishing Company).